Referências
Principais artigos
American Diabetes Association. Standards of care in diabetes - 2024. Diabetes Care. 2024 Jan;47(suppl 1):S1-321.Texto completo
Moghissi ES, Korytkowski MT, DiNardo M, et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Endocr Pract. 2009 May-Jun;15(4):353-69. Resumo
Pasquel FJ, Lansang MC, Dhatariya K, et al. Management of diabetes and hyperglycaemia in the hospital. Lancet Diabetes Endocrinol. 2021 Mar;9(3):174-88.Texto completo Resumo
Finfer S, Chittock DR, Su SY, et al; NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009 Mar 26;360(13):1283-97.Texto completo Resumo
Umpierrez G, Smiley D, Zisman A, et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care. 2007 Sep;30(9):2181-6.Texto completo Resumo
Artigos de referência
1. American Diabetes Association. Standards of care in diabetes - 2024. Diabetes Care. 2024 Jan;47(suppl 1):S1-321.Texto completo
2. Diabetes Canada (Canadian Diabetes Association). Clinical practice guidelines for the prevention and management of diabetes in Canada. 2018 [internet publication].Texto completo
3. Moghissi ES, Korytkowski MT, DiNardo M, et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Endocr Pract. 2009 May-Jun;15(4):353-69. Resumo
4. Korytkowski MT, Muniyappa R, Antinori-Lent K, et al. Management of hyperglycemia in hospitalized adult patients in non-critical care settings: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2022 Jul 14;107(8):2101-28.Texto completo Resumo
5. Umpierrez GE, Isaacs SD, Bazargan N, et al. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002 Mar;87(3):978-82.Texto completo Resumo
6. Levetan CS, Magee MF. Hospital management of diabetes. Endocrinol Metab Clin North Am. 2000 Dec;29(4):745-70. Resumo
7. Finney SJ, Zekveld C, Elia A, et al. Glucose control and mortality in critically ill patients. JAMA. 2003 Oct 15;290(15):2041-7.Texto completo Resumo
8. Fonseca V. Newly diagnosed diabetes/hyperglycemia in hospitals: what should we do? Endocr Pract. 2006 Jul-Aug;12 Suppl 3:108-11. Resumo
9. Inzucchi SE. Clinical practice: management of hyperglycemia in the hospital setting. N Engl J Med. 2006 Nov 2;355(18):1903-11. Resumo
10. Pasquel FJ, Smiley D, Spiegelman R, et al. Hyperglycemia is associated with increased hospital complications and mortality during parenteral nutrition. Hosp Pract (Minneap). 2011 Apr;39(2):81-8. Resumo
11. ACE/ADA Task Force on Inpatient Diabetes. American College of Endocrinology and American Diabetes Association consensus statement on inpatient diabetes and glycemic control. Endocr Pract. 2006 Jul-Aug;12(4):458-68. Resumo
12. Barker HL, Morrison D, Llano A, et al. Practical guide to glucocorticoid induced hyperglycaemia and diabetes. Diabetes Ther. 2023 May;14(5):937-45.Texto completo Resumo
13. Kornum JB, Thomsen RW, Riis A, et al. Diabetes, glycemic control, and risk of hospitalization with pneumonia: a population-based case-control study. Diabetes Care. 2008 Aug;31(8):1541-5.Texto completo Resumo
14. Kwon S, Hermayer KL. Glucocorticoid-induced hyperglycemia. Am J Med Sci. 2013 Apr;345(4):274-7. Resumo
15. Farrokhi F, Klindukhova O, Chandra P, et al. Risk factors for inpatient hypoglycemia during subcutaneous insulin therapy in non-critically ill patients with type 2 diabetes. J Diabetes Sci Technol. 2012 Sep 1;6(5):1022-9.Texto completo Resumo
16. Dabelea D, Rewers A, Stafford JM, et al; SEARCH for Diabetes in Youth Study Group. Trends in the prevalence of ketoacidosis at diabetes diagnosis: the SEARCH for Diabetes in Youth study. Pediatrics. 2014 Apr;133(4):e938-45.Texto completo Resumo
17. Jones AG, Hattersley AT. The clinical utility of C-peptide measurement in the care of patients with diabetes. Diabet Med. 2013 Jul;30(7):803-17.Texto completo Resumo
18. Lampasona V, Petrone A, Tiberti C, et al; Non Insulin Requiring Autoimmune Diabetes (NIRAD) Study Group. Zinc transporter 8 antibodies complement GAD and IA-2 antibodies in the identification and characterization of adult-onset autoimmune diabetes: Non Insulin Requiring Autoimmune Diabetes (NIRAD) 4. Diabetes Care. 2010 Jan;33(1):104-8.Texto completo Resumo
19. Sacks DB, Arnold M, Bakris GL, et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care. 2023 Oct 1;46(10):e151-e199.Texto completo Resumo
20. Pasquel FJ, Lansang MC, Dhatariya K, et al. Management of diabetes and hyperglycaemia in the hospital. Lancet Diabetes Endocrinol. 2021 Mar;9(3):174-88.Texto completo Resumo
21. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001 Nov 8;345(19):1359-67.Texto completo Resumo
22. Marik PE, Preiser JC. Toward understanding tight glycemic control in the ICU: a systematic review and metaanalysis. Chest. 2010 Mar;137(3):544-51. Resumo
23. Finfer S, Chittock DR, Su SY, et al; NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009 Mar 26;360(13):1283-97.Texto completo Resumo
24. Umpierrez G, Smiley D, Zisman A, et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care. 2007 Sep;30(9):2181-6.Texto completo Resumo
25. Umpierrez GE, Smiley D, Jacobs S, et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care. 2011 Feb;34(2):256-61.Texto completo Resumo
26. Pasquel FJ, Lansang MC, Khowaja A, et al. A randomized controlled trial comparing glargine U300 and glargine U100 for the inpatient management of medicine and surgery patients with type 2 diabetes: Glargine U300 hospital trial. Diabetes Care. 2020 Jun;43(6):1242-8.Texto completo Resumo
27. Suzuki J, Yamakawa T, Oba M, et al. Efficacy and safety of insulin degludec U100 and insulin glargine U100 in combination with meal-time bolus insulin in hospitalized patients with type 2 diabetes: an open-label, randomized controlled study. Endocr J. 2019 Nov 28;66(11):971-82.Texto completo Resumo
28. Umpierrez GE, Smiley D, Hermayer K, et al. Randomized study comparing a basal-bolus with a basal plus correction insulin regimen for the hospital management of medical and surgical patients with type 2 diabetes: Basal Plus trial. Diabetes Care. 2013 Aug;36(8):2169-74.Texto completo Resumo
29. Vellanki P, Bean R, Oyedokun FA, et al. Randomized controlled trial of insulin supplementation for correction of bedtime hyperglycemia in hospitalized patients with type 2 diabetes. Diabetes Care. 2015 Apr;38(4):568-74.Texto completo Resumo
30. Svensson AM, McGuire DK, Abrahamsson P, et al. Association between hyper- and hypoglycemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events. Eur Heart J. 2005 Jul;26(13):1255-61.Texto completo Resumo
31. Dumont C, Bourguignon C. Effect of a computerized insulin dose calculator on the process of glycemic control. Am J Crit Care. 2012 Mar;21(2):106-15. Resumo
32. Steil GM, Langer M, Jaeger K, et al. Value of continuous glucose monitoring for minimizing severe hypoglycemia during tight glycemic control. Pediatr Crit Care Med. 2011 Nov;12(6):643-8.Texto completo Resumo
33. Klonoff DC. Intensive insulin therapy in critically ill hospitalized patients: making it safe and effective. J Diabetes Sci Technol. 2011 May 1;5(3):755-67.Texto completo Resumo
34. Goldberg PA, Siegel MD, Sherwin RS, et al. Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. Diabetes Care. 2004 Feb;27(2):461-7.Texto completo Resumo
35. Adams G, Hunter J, Langley J, et al. Is nurse-managed blood glucose control in critical care as safe and effective as the traditional sliding scale method? Intensive Crit Care Nurs. 2009 Dec;25(6):294-305. Resumo
36. American Society of Anesthesiologists. American Society of Anesthesiologists consensus-based guidance on preoperative management of patients (adults and children) on glucagon-like peptide-1 (GLP-1) receptor agonists. 2023 [internet publication].Texto completo
37. Bloomgarden Z. Should glucagon-like peptide-1 receptor agonist treatment be withheld in preoperative management? J Diabetes. 2023 Sep;15(9):712-3.Texto completo Resumo
38. Thiruvenkatarajan V, Meyer EJ, Nanjappa N, et al. Perioperative diabetic ketoacidosis associated with sodium-glucose co-transporter-2 inhibitors: a systematic review. Br J Anaesth. 2019 Jul;123(1):27-36.Texto completo Resumo
39. Singh LG, Ntelis S, Siddiqui T, et al. Association of continued use of SGLT2 inhibitors from the ambulatory to inpatient setting with hospital outcomes in patients with diabetes: a nationwide cohort study. Diabetes Care. 5 Dec 2023 [Epub ahead of print]. Resumo
40. Pasquel FJ, Gianchandani R, Rubin DJ, et al. Efficacy of sitagliptin for the hospital management of general medicine and surgery patients with type 2 diabetes (Sita-Hospital): a multicentre, prospective, open-label, non-inferiority randomised trial. Lancet Diabetes Endocrinol. 2017 Feb;5(2):125-33. Resumo
41. Garg R, Schuman B, Hurwitz S, et al. Safety and efficacy of saxagliptin for glycemic control in non-critically ill hospitalized patients. BMJ Open Diabetes Res Care. 2017 Mar 29;5(1):e000394.Texto completo Resumo
42. Vellanki P, Rasouli N, Baldwin D, et al. Glycaemic efficacy and safety of linagliptin compared to a basal-bolus insulin regimen in patients with type 2 diabetes undergoing non-cardiac surgery: a multicentre randomized clinical trial. Diabetes Obes Metab. 2019 Apr;21(4):837-43. Resumo
43. Joint British Diabetes Societies for Inpatient Care. The hospital management of hypoglycaemia in adults with diabetes mellitus. Jan 2023 [internet publication].Texto completo
44. Agus MS, Steil GM, Wypij D, et al; SPECS Study Investigators. Tight glycemic control versus standard care after pediatric cardiac surgery. N Engl J Med. 2012 Sep 27;367(13):1208-19.Texto completo Resumo
45. Agus MS, Wypij D, Hirshberg EL, et al; HALF-PINT Study Investigators and the PALISI Network. Tight glycemic control in critically ill children. N Engl J Med. 2017 Feb 23;376(8):729-41.Texto completo Resumo
46. Bielen I, Sruk A, Zalac D. Specificity of hyperglycemia treatment in acute stroke patients. Acta Med Croatica. 2008 Jul;62(3):273-80. Resumo
47. Ooi YC, Dagi TF, Maltenfort M, et al. Tight glycemic control reduces infection and improves neurological outcome in critically ill neurosurgical and neurological patients. Neurosurgery. 2012 Sep;71(3):692-702. Resumo
48. Rickels MR, Ruedy KJ, Foster NC, et al; T1D Exchange Intranasal Glucagon Investigators. Intranasal glucagon for treatment of insulin-induced hypoglycemia in adults with type 1 diabetes: a randomized crossover noninferiority study. Diabetes Care. 2016 Feb;39(2):264-70.Texto completo Resumo
49. Christiansen MP, Cummins MJ, Prestrelski SJ, et al. A phase 3 comparison of a novel liquid glucagon autoinjector to glucagon emergency kit for the symptomatic relief of severe hypoglycemia. Paper presented at: American Diabetes Association 78th Scientific Sessions. 22-26 Jun 2018. Orlando, Florida, US. Oral presentations: clinical diabetes/therapeutics. Diabetes. 2018 Jul; 67(Supplement 1):304-OR.Texto completo
50. Singh LG, Satyarengga M, Marcano I, et al. Reducing inpatient hypoglycemia in the general wards using real-time continuous glucose monitoring: the glucose telemetry system, a randomized clinical trial. Diabetes Care. 2020 Nov;43(11):2736-43.Texto completo Resumo
51. Perez-Guzman MC, Shang T, Zhang JY, et al. Continuous glucose monitoring in the hospital. Endocrinol Metab (Seoul). 2021 Apr;36(2):240-55.Texto completo Resumo
52. Spanakis EK, Urrutia A, Galindo RJ, et al. Continuous glucose monitoring-guided insulin administration in hospitalized patients with diabetes: a randomized clinical trial. Diabetes Care. 2022 Oct 1;45(10):2369-75.Texto completo Resumo
53. Finn E, Schlichting L, Grau L, et al. Real-world accuracy of CGM in inpatient critical and noncritical care settings at a safety-net hospital. Diabetes Care. 2023 Oct 1;46(10):1825-30.Texto completo Resumo
54. Voglová Hagerf B, Protus M, Nemetova L, et al. Accuracy and feasibility of real-time continuous glucose monitoring in critically ill patients after abdominal surgery and solid organ transplantation. Diabetes Care. 27 Feb 2024 [Epub ahead of print]. Resumo
55. McCall AL, Lieb DC, Gianchandani R, et al. Management of individuals with diabetes at high risk for hypoglycemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2023 Mar;108(3):529-62.Texto completo Resumo
O uso deste conteúdo está sujeito ao nosso aviso legal